TRYM Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10
Best for: low-cost compounded GLP-1 vials shipped nationwide
TRYM Health scores below our bar on medical oversight — read the score breakdown before signing up.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
TRYM Health (TRYM) is a nationwide telehealth service offering compounded GLP-1 weight-loss medication — semaglutide (~$96/mo, $3.20/day) and tirzepatide (~$126/mo, $4.20/day) — as additive-free multi-dose vials covering all doses, with a starter kit, temperature-controlled shipping, FSA/HSA eligibility, and flexible cancellation. Available in all 50 states; it also offers wellness and hair-care plans. Operated by TRYM Health, Inc.; medications are compounded by unnamed partner pharmacies, and the site shows no LegitScript certification.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to TRYM Health
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
TRYM Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $96/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- 1 FDA warning letter on record — see below
How we scored TRYM Health
Each dimension is scored algorithmically from TRYM Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.9/10At $96/mo, TRYM Health runs about 43% below the $170 median for GLP-1 providers.
Effectiveness25%
7.9/10TRYM Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.2/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
5.1/10Core details confirmed by our editors; an FDA warning letter is on file (see flag above).
Accessibility10%
8.5/10TRYM Health treats patients in all 50 states. FSA/HSA cards are accepted.
Support10%
5.7/10TRYM Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this TRYM Health review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $96–$126/mo across 2 dose/plan tiers — checked August 2026
- FDA warning-letter register
- An active letter is on file for this provider — see below
What to expect when you sign up with TRYM Health
We walked TRYM Health’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Make an account (about 2 minutes).
- 2Fill out the registration intake form during signup.
- 3Complete payment and choose a subscription/wellness plan.
- 4A partnered provider reviews your order, then you're notified when it's dispatched.
- Services page lists compounded GLP-1 and GLP-1+GIP multi-dose vials with priced plans 'as low as $3.20/day' (GLP-1) and '$4.20/day' (GLP-1+GIP), visible before intake.
- Explicitly states compounded drugs are not FDA-approved.
- Promotes a flexible cancellation policy, free shipping, and FSA/HSA eligibility.
- Ships in an insulated temperature-monitored box; available in all 50 states.
- TRYM describes itself as a subscription-management platform, not a direct medical/pharmacy provider.
TRYM Health customer support
- Phone
- (347) 450-9244
- Hours
- 9 AM - 5 PM, Monday - Friday
GLP-1 medications TRYM Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
⚠ TRYM prices PER DAY, not per month. The figure here is $3.20/day × 30 — our arithmetic on the seller's only published unit, not a rate TRYM quotes.
⚠ Same derivation: the site's only public figure is 'Plans starting at as low as $4.20/day'. × 30 gives $126.
Ready to get started?
Plans and promotions change often — check TRYM Health's current pricing and active discounts before you decide.
What we like
- Affordable compounded GLP-1 — semaglutide ~$96/mo ($3.20/day) and tirzepatide ~$126/mo ($4.20/day)
- Available in all 50 states with free shipping and FSA/HSA eligibility
- Multi-dose vials cover all doses up to the maximum; additive-free, with a full starter kit
- Temperature-controlled insulated shipping and flexible cancellation
Watch-outs
- Compounding pharmacy partner not named
- Not LegitScript-certified (no certification displayed)
- Lowest per-day pricing likely requires a longer prepaid plan commitment
- Drugs labeled generically as 'GLP-1' / 'GLP-1 + GIP' on the services page rather than named
Is TRYM Health worth it?
TRYM Health built its program around one core idea: low-cost compounded GLP-1 vials shipped nationwide. It runs $96/month — toward the affordable end of the category, so cost isn't the reason to look elsewhere. It treats patients in every state, so where you live isn't a reason to rule it out.
TRYM Health takes HSA/FSA payment and ships cold-chain.
How much TRYM Health actually costs
Compounded semaglutide runs $96/month and compounded tirzepatide runs $126/month.
That puts TRYM Health below the roughly $170 median ongoing price across the GLP-1 providers we track — a real cost advantage.
bmiMD (about $99/month) is one of the closest alternatives to weigh TRYM Health against.
Medications: what TRYM Health prescribes
TRYM Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who TRYM Health is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost — $96/month is below the roughly $170 median we track across the category.
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
- want a provider with a clean regulatory record — note the FDA warning flagged at the top of this page.
Trust, safety, and medical oversight
TRYM Health treats patients in all 50 states, and it does have an FDA warning letter on file, which we flag at the top of this review — read it before starting. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
TRYM Health earns its place mainly on price: at $96/month it's one of the more affordable ways to stay on a GLP-1. One important caveat: it has an FDA warning letter on file — read it (flagged at the top of this review) and talk with a clinician before choosing it.
The Bottom Line
TRYM Health scores below our bar on medical oversight — read the score breakdown before signing up.
Ready to start with TRYM Health?
Starting at $96/month. See current pricing and start your free consultation.
TRYM Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Fella Health.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
TRYM Health received an FDA warning letter dated September 9, 2025
The letter concerns unlawful sale of unapproved and misbranded drugs to united states consumers over the internet (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity — companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this TRYM Health review:
Sources & methodology — as of September 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See TRYM Health's current pricing
Plans start at $96/month. Start your free consultation to check eligibility and today's price.